Delivery Order SPE2DB22D1106-SPE2DB25FFHM1
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lamotrigine ODT 200 mg tablets in quantities of 30 units, valued at $1,269.11. This firm fixed-price delivery order, set to be completed by August 8, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was competitively awarded without set-aside provisions, reflecting the vendor's demonstrated capability...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566320992 units of Lamotrigine ODT 100 mg Tablets. The contract has a ceiling value of $1,564.64 and will run through November 5, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,258,825 units of the pharmaceutical product LAMOTRIGINE ODT 50 MG TABLET 30S. The contract has a ceiling value of $2,579.51 and a period of performance through April 15, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.28 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,824.31 to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used for seizure management and bipolar...
- The Defense Logistics Agency awarded a $2,448.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 lamotrigine orally disintegrating tablets, 100 mg each. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by August 15, 2023. No...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of lamotrigine orally disintegrating tablets (50 mg, 30-count). The contract has a ceiling value of $2,561.59 and a period of performance ending on June 25, 2025. The contract is a firm-fixed-price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,910.41 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets (30-count packages). This contract, awarded on August 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lamotrigine ER 200 mg tablets in 30-count quantities. This contract, valued at $1,133.76, represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ODT 50 mg tablets, a medication used to treat certain types of seizures. The contract has a ceiling value of $20,267.48 and is a firm fixed-price, non-set-aside contract with a period of performance through May 9, 2025. AmerisourceBergen holds a significant Indefinite...